Reuters logo
BRIEF-Veloxis Pharmaceuticals Q1 operating loss narrows to $5.2 mln
May 17, 2017 / 5:25 AM / 6 months ago

BRIEF-Veloxis Pharmaceuticals Q1 operating loss narrows to $5.2 mln

May 17 (Reuters) - VELOXIS PHARMACEUTICALS A/S:

* SAID ON TUESDAY Q1 REVENUE $4.0 MLN VS $1.5 MLN YR AGO

* Q1 OPERATING LOSS $5.2 MLN VS LOSS $6.9 MLN YR AGO

* Q1 NET LOSS $5.9 MLN VS LOSS $7.1 MLN YR AGO

* VELOXIS MAINTAINS ITS 2017 OUTLOOK OF OPERATING LOSS BEFORE THE RECOGNITION OF INCOME FROM LICENSE AGREEMENTS AND BEFORE ACCOUNTING FOR STOCK COMPENSATION TO BE IN THE RANGE OF USD 5 – 15 MILLION.

Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below